NEW YORK (GenomeWeb) – Qiagen said after the close of the market on Friday that it is transferring the US listing of its global shares to the New York Stock Exchange from the Nasdaq Global Market. The transfer is expected to be effective on or about Jan. 10, 2018. Qiagen's shares will continue to trade on the Nasdaq until the transfer is completed. The company's shares will continue to trade under the ticker "QGEN" after the transfer, and there will be no impact on the trading of Qiagen's global shares on the Frankfurt Stock Exchange under the ticker "QIA."

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

In PLOS this week: grey wolf population genomics, mutations associated with lung adenocarcinoma survival, and more.

An opinion piece at Bloomberg discusses China's stance on genomic research.

Genetic ancestry testing can affect a person's sense of identity, the New York Times Magazine writes.

Nebula Genomics is launching its genome sequencing service for free for people who provide certain information about themselves, the Boston Globe reports.